Autonomix (AMIX, Financial) Medical has been granted U.S. Patent No. 12,295,646 by the United States Patent and Trademark Office. This patent covers a smart torquer device aimed at improving the manipulation of elongated intravascular devices used in minimally invasive medical procedures. The device incorporates electronic components to enhance both mechanical control and data communication capabilities.
The smart torquer is expected to significantly enhance control and signal integration in intravascular procedures. This advancement is crucial for Autonomix as it seeks to expand its platform into rapidly growing fields such as cardiology, neurosurgery, and interventional radiology. With this latest addition, the company now holds over 80 patents, strengthening its position in a lucrative market poised for precision nerve-targeted interventions that could transform clinical outcomes.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 2 analysts, the average target price for Autonomix Medical Inc (AMIX, Financial) is $11.50 with a high estimate of $18.00 and a low estimate of $5.00. The average target implies an upside of 627.85% from the current price of $1.58. More detailed estimate data can be found on the Autonomix Medical Inc (AMIX) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, Autonomix Medical Inc's (AMIX, Financial) average brokerage recommendation is currently 1.5, indicating "Buy" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
